Valneva, Pfizer announce positive phase 2 paediatric data for Lyme disease vaccine candidate

MLA

“Valneva, Pfizer Announce Positive Phase 2 Paediatric Data for Lyme Disease Vaccine Candidate.” PharmaBiz, Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.701705727&authtype=sso&custid=ns315887.

APA

Valneva, Pfizer announce positive phase 2 paediatric data for Lyme disease vaccine candidate. (2022, April 27). PharmaBiz.

Chicago

PharmaBiz. 2022. “Valneva, Pfizer Announce Positive Phase 2 Paediatric Data for Lyme Disease Vaccine Candidate,” April 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.701705727&authtype=sso&custid=ns315887.